Health Care & Life Sciences » Pharmaceuticals | Lansen Pharmaceutical Holdings Ltd.

Lansen Pharmaceutical Holdings Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
198
333
332
288
339
263
Total Accounts Receivable
374
543
437
505
559
477
Inventories
133
131
135
113
102
94
Other Current Assets
-
75
-
-
-
15
Total Current Assets
780
1,007
905
907
1,000
848
Net Property, Plant & Equipment
271
270
260
240
246
221
Total Investments and Advances
264
272
261
323
277
236
Intangible Assets
156
234
248
242
241
256
Other Assets
19
19
17
16
16
20
Total Assets
1,492
1,801
1,692
1,727
1,780
1,581
ST Debt & Current Portion LT Debt
459
658
689
815
775
Accounts Payable
80
116
89
98
60
Income Tax Payable
12
14
11
11
9
Other Current Liabilities
80
117
96
88
123
Total Current Liabilities
631
905
885
1,012
967
Long-Term Debt
-
-
8
-
-
Deferred Taxes
3
8
12
15
16
Total Liabilities
634
913
906
1,026
983
Common Equity (Total)
858
889
786
701
798
Total Shareholders' Equity
858
889
786
701
798
Total Equity
858
889
786
701
798
Liabilities & Shareholders' Equity
1,492
1,801
1,692
1,727
1,780

About Lansen Pharmaceutical Holdings

View Profile
Address
228 Xinfeng Road
Ningbo Zhejiang 315174
China
Employees -
Website http://www.lansen.com.cn
Updated 07/08/2019
Lansen Pharmaceutical Holdings Ltd. engages in the development, manufacture, and distribution of pharmaceuticals products. It operates through the following segments: Pharmaceuticals, Medicinal Cosmetics Products, and Healthcare Products. The Pharmaceuticals segment develops, produces, and sells specialty pharmaceuticals mainly used in the field of rheumatology and dermatology and other pharmaceuticals.